标题
CXCR2 in Acute Lung Injury
作者
关键词
-
出版物
MEDIATORS OF INFLAMMATION
Volume 2012, Issue -, Pages 1-8
出版商
Hindawi Limited
发表日期
2012-06-07
DOI
10.1155/2012/740987
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Simvastatin regulates CXC chemokine formation in streptococcal M1 protein-induced neutrophil infiltration in the lung
- (2011) Songen Zhang et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- SB-656933, a novel CXCR2 selective antagonist, inhibits ex vivo neutrophil activation and ozone-induced airway inflammation in humans
- (2011) Aili L. Lazaar et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Receptor binding mode and pharmacological characterization of a potent and selective dual CXCR1/CXCR2 non-competitive allosteric inhibitor
- (2011) R Bertini et al. BRITISH JOURNAL OF PHARMACOLOGY
- Expression of the inflammatory chemokines CCL2, CCL5 and CXCL2 and the receptors CCR1–3 and CXCR2 in T lymphocytes from mammary tumor-bearing mice
- (2011) Jennifer L. Owen et al. CELLULAR IMMUNOLOGY
- The role of CXCR2 chemokine receptors in the oral squamous cell carcinoma
- (2011) Juliana Romanini et al. INVESTIGATIONAL NEW DRUGS
- Targeting chemokine receptors in chronic inflammatory diseases: An extensive review
- (2011) Pim J. Koelink et al. PHARMACOLOGY & THERAPEUTICS
- Combined CXCR1/CXCR2 Antagonism Decreases Radiation-Induced Alveolitis in the Mouse
- (2011) Jessica Fox et al. RADIATION RESEARCH
- Neutrophils in chronic inflammatory airway diseases: can we target them and how?
- (2010) Y. Gernez et al. EUROPEAN RESPIRATORY JOURNAL
- Importance of CXC Chemokine Receptor 2 in Alveolar Neutrophil and Exudate Macrophage Recruitment in Response to Pneumococcal Lung Infection
- (2010) W. Herbold et al. INFECTION AND IMMUNITY
- CXCR2 and CXCR4 antagonistically regulate neutrophil trafficking from murine bone marrow
- (2010) Kyle J. Eash et al. JOURNAL OF CLINICAL INVESTIGATION
- Pharmacological targeting reveals distinct roles for CXCR2/CXCR1 and CCR2 in a mouse model of arthritis
- (2009) Soo-Hong Min et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- SCH527123, a novel CXCR2 antagonist, inhibits ozone-induced neutrophilia in healthy subjects
- (2009) O. Holz et al. EUROPEAN RESPIRATORY JOURNAL
- The functional significance behind expressing two IL-8 receptor types on PMN
- (2009) RoseMarie Stillie et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Blockade of neutrophil responses in aspiration pneumonia via ELR-CXC chemokine antagonism does not predispose to airway bacterial outgrowth
- (2009) Xixing Zhao et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Amelioration of Pathology by ELR-CXC Chemokine Antagonism in a Swine Model of Airway Endotoxin Exposure
- (2009) John R. Gordon et al. Journal of Agromedicine
- Role of the Chemokine Receptor CXCR2 in Bleomycin-Induced Pulmonary Inflammation and Fibrosis
- (2008) Remo C. Russo et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- CXCR2 chemokine receptor antagonism enhances DOP opioid receptor function via allosteric regulation of the CXCR2–DOP receptor heterodimer
- (2008) Geraldine Parenty et al. BIOCHEMICAL JOURNAL
- Migration across the sinusoidal endothelium regulates neutrophil mobilization in response to ELR + CXC chemokines
- (2008) Peter C. E. Burdon et al. BRITISH JOURNAL OF HAEMATOLOGY
- Therapeutic inhibition of CXCR2 by Reparixin attenuates acute lung injury in mice
- (2008) A Zarbock et al. BRITISH JOURNAL OF PHARMACOLOGY
- Hepatocyte signaling through CXC chemokine receptor-2 is detrimental to liver recovery after ischemia/reperfusion in mice
- (2008) Satoshi Kuboki et al. HEPATOLOGY
- CXCR2 antagonists for the treatment of pulmonary disease
- (2008) R.W. Chapman et al. PHARMACOLOGY & THERAPEUTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started